DOCSLIB.ORG

Rabbit Anti-GLS2/FITC Conjugated Antibody

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rabbit Anti-GLS2/FITC Conjugated Antibody SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-GLS2/FITC Conjugated antibody SL13376R-FITC Product Name: Anti-GLS2/FITC Chinese Name: FITC标记的谷氨酰胺酰胺水解酶抗体 breast cell glutaminase; Gls2; GLSL_HUMAN; glutaminase 2 (liver mitochondrial); glutaminase 2; glutaminase GA; glutaminase I; Glutaminase liver isoform; hLGA; L Alias: glutaminase; L glutamine amidohydrolase; L-glutaminase; L-glutamine amidohydrolase; LGA; mitochondrial; phosphate activated glutaminase; phosphate- dependent glutaminase. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 65kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human GLS2/LGA Lsotype: IgGwww.sunlongbiotech.com Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: LGA is a 602 amino acid protein that localizes to the mitochondrion and contains two ANK repeats. Expressed in brain, liver and pancreas, LGA functions as a mitochondrial Product Detail: phosphate-activated glutaminase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. LGA is overexpressed in breast cancer cell lines, suggesting a role for LGA in tumorigenesis. The gene encoding LGA maps to human chromosome 12, which encodes over 1,100 genes and comprises approximately 4.5% of the human genome. Chromosome 12 is associated with a variety of diseases and afflictions, including hypochondrogenesis, achondrogenesis, Kniest dysplasia, Noonan syndrome and Trisomy 12p, which causes facial developmental defects and seizure disorders. Function: Plays an important role in the regulation of glutamine catabolism. Promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. Increases cellular anti-oxidant function via NADH and glutathione production. May play a role in preventing tumor proliferation. Subunit: Interacts with the PDZ domain of the syntrophin SNTA1.Interacts with the PDZ domain of TAX1BP3. Subcellular Location: Mitochondrion. Tissue Specificity: Highly expressed in liver. Expressed in brain and pancreas. Not observed in heart, placenta, lung, skeletal muscle and kidney. Expression is significantly reduced in hepatocellular carcinomas. Similarity: Belongs to the glutaminase family. Contains 2 ANK repeats. Database links: Entrez Gene: 27165Human Entrez Gene: 216456Mouse Entrezwww.sunlongbiotech.com Gene: 192268Rat Omim: 606365Human SwissProt: Q9UI32Human SwissProt: Q571F8Mouse SwissProt: P28492Rat Unigene: 212606Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. www.sunlongbiotech.com.
Load more

Recommended publications
  • PARSANA-DISSERTATION-2020.Pdf
    DECIPHERING TRANSCRIPTIONAL PATTERNS OF GENE REGULATION: A COMPUTATIONAL APPROACH by Princy Parsana A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland July, 2020 © 2020 Princy Parsana All rights reserved Abstract With rapid advancements in sequencing technology, we now have the ability to sequence the entire human genome, and to quantify expression of tens of thousands of genes from hundreds of individuals. This provides an extraordinary opportunity to learn phenotype relevant genomic patterns that can improve our understanding of molecular and cellular processes underlying a trait. The high dimensional nature of genomic data presents a range of computational and statistical challenges. This dissertation presents a compilation of projects that were driven by the motivation to efficiently capture gene regulatory patterns in the human transcriptome, while addressing statistical and computational challenges that accompany this data. We attempt to address two major difficulties in this domain: a) artifacts and noise in transcriptomic data, andb) limited statistical power. First, we present our work on investigating the effect of artifactual variation in gene expression data and its impact on trans-eQTL discovery. Here we performed an in-depth analysis of diverse pre-recorded covariates and latent confounders to understand their contribution to heterogeneity in gene expression measurements. Next, we discovered 673 trans-eQTLs across 16 human tissues using v6 data from the Genotype Tissue Expression (GTEx) project. Finally, we characterized two trait-associated trans-eQTLs; one in Skeletal Muscle and another in Thyroid. Second, we present a principal component based residualization method to correct gene expression measurements prior to reconstruction of co-expression networks.
    [Show full text]
  • Glutaminase 2 Induces Interleukin-2 Production in CD4+ T Cells by Supporting Antioxidant Defense
    Glutaminase 2 Induces Interleukin-2 Production in CD4+ T Cells by Supporting Antioxidant Defense The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Orite, Seo Yeon Kim. 2019. Glutaminase 2 Induces Interleukin-2 Production in CD4+ T Cells by Supporting Antioxidant Defense. Master's thesis, Harvard Medical School. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:42057407 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use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
    [Show full text]
  • Identification the Ferroptosis-Related Gene Signature in Patients with Esophageal Adenocarcinoma
    Zhu et al. Cancer Cell Int (2021) 21:124 https://doi.org/10.1186/s12935-021-01821-2 Cancer Cell International PRIMARY RESEARCH Open Access Identifcation the ferroptosis-related gene signature in patients with esophageal adenocarcinoma Lei Zhu1,2,3†, Fugui Yang1,2†, Lingwei Wang1,2, Lin Dong1,2, Zhiyuan Huang1,2, Guangxue Wang2, Guohan Chen1* and Qinchuan Li1,2* Abstract Background: Ferroptosis is a recently recognized non-apoptotic cell death that is distinct from the apoptosis, necroptosis and pyroptosis. Considerable studies have demonstrated ferroptosis is involved in the biological process of various cancers. However, the role of ferroptosis in esophageal adenocarcinoma (EAC) remains unclear. This study aims to explore the ferroptosis-related genes (FRG) expression profles and their prognostic values in EAC. Methods: The FRG data and clinical information were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate cox regressions were used to identify the prognostic FRG, and the predictive ROC model was established using the independent risk factors. GO and KEGG enrichment analyses were performed to investi- gate the bioinformatics functions of signifcantly diferent genes (SDG) of ferroptosis. Additionally, the correlations of ferroptosis and immune cells were assessed through the single-sample gene set enrichment analysis (ssGSEA) and TIMER database. Finally, SDG were verifed in clinical EAC specimens and normal esophageal mucosal tissues. Results: Twenty-eight signifcantly diferent FRG were screened from 78 EAC and 9 normal tissues. Enrichment analyses showed these SDG were mainly related to the iron-related pathways and metabolisms of ferroptosis. Gene network demonstrated the TP53, G6PD, NFE2L2 and PTGS2 were the hub genes in the biology of ferroptosis.
    [Show full text]
  • The Fundamental Role of the P53 Pathway in Tumor Metabolism and Its Implication in Tumor Therapy
    Author Manuscript Published OnlineFirst on February 3, 2012; DOI: 10.1158/1078-0432.CCR-11-3040 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy Lan Shen1，Xiang Sun2，Zhenhong Fu3，Guodong Yang1，Jianying Li1，and Libo Yao1,* 1 Department of Biochemistry and Molecular Biology, The State Key Laboratory of Cancer Biology, The Fourth Military Medical University, Xi’an 710032, The People’s Republic of China 2 Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, The People’s Republic of China 3 Department of Cardiology, The General Hospital of the People’s Liberation Army, Beijing 100853, The People’s Republic of China L. Shen, X. Sun and Z-H. Fu contributed equally to this work. * Corresponding author: Department of Biochemistry and Molecular Biology, The State Key Laboratory of Cancer Biology, The Fourth Military Medical University, Xi’an 710032, The People’s Republic of China. Phone: 86-29-84774513; Fax: 86-29-84773947; E-mail: [email protected]. Statement of translational relevance The tumor suppressor p53 is one of the most highly studied in the field of cancer research due to its functions on tumor cell survival and apoptosis. However, tumor metabolic reprogramming fuels cancer cell malignant growth and proliferation. In this review, we systematically document the mechanisms of p53 in tumor metabolism regulation. On this basis, we analyzed the therapeutic strategy whereby p53 helps to prevent tumor malignant metabolic phenotype, bioenergetic, and biosynthetic processes, and blocking the reprogramming of tumor metabolism will provide new strategies for tumor therapy.
    [Show full text]
  • Characterization of the Scavenger Cell Proteome in Mouse and Rat Liver
    Biol. Chem. 2021; 402(9): 1073–1085 Martha Paluschinski, Cheng Jun Jin, Natalia Qvartskhava, Boris Görg, Marianne Wammers, Judith Lang, Karl Lang, Gereon Poschmann, Kai Stühler and Dieter Häussinger* Characterization of the scavenger cell proteome in mouse and rat liver + https://doi.org/10.1515/hsz-2021-0123 The data suggest that the population of perivenous GS Received January 25, 2021; accepted July 4, 2021; scavenger cells is heterogeneous and not uniform as previ- published online July 30, 2021 ously suggested which may reflect a functional heterogeneity, possibly relevant for liver regeneration. Abstract: The structural-functional organization of ammonia and glutamine metabolism in the liver acinus involves highly Keywords: glutaminase; glutamine synthetase; liver specialized hepatocyte subpopulations like glutamine syn- zonation; proteomics; scavenger cells. thetase (GS) expressing perivenous hepatocytes (scavenger cells). However, this cell population has not yet been char- acterized extensively regarding expression of other genes and Introduction potential subpopulations. This was investigated in the present study by proteome profiling of periportal GS-negative and There is a sophisticated structural-functional organization in perivenous GS-expressing hepatocytes from mouse and rat. the liver acinus with regard to ammonium and glutamine Apart from established markers of GS+ hepatocytes such as metabolism (Frieg et al. 2021; Gebhardt and Mecke 1983; glutamate/aspartate transporter II (GLT1) or ammonium Häussinger 1983, 1990). Periportal hepatocytes express en- transporter Rh type B (RhBG), we identified novel scavenger zymes required for urea synthesis such as the rate-controlling cell-specific proteins like basal transcription factor 3 (BTF3) enzyme carbamoylphosphate synthetase 1 (CPS1) and liver- and heat-shock protein 25 (HSP25).
    [Show full text]
  • (KGA) and Its Regulation by Raf-Mek-Erk Signaling in Cancer Cell Metabolism
    Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism K. Thangavelua,1, Catherine Qiurong Pana,b,1, Tobias Karlbergc, Ganapathy Balajid, Mahesh Uttamchandania,d,e, Valiyaveettil Sureshd, Herwig Schülerc, Boon Chuan Lowa,b,2, and J. Sivaramana,2 Departments of aBiological Sciences and dChemistry, National University of Singapore, Singapore 117543; bMechanobiology Institute Singapore, National University of Singapore, Singapore 117411; cStructural Genomics Consortium, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm SE-17177, Sweden; and eDefence Medical and Environmental Research Institute, DSO National Laboratories, Singapore 117510 Edited by John Kuriyan, University of California, Berkeley, CA, and approved March 22, 2012 (received for review October 11, 2011) Besides thriving on altered glucose metabolism, cancer cells un- a substrate for the ubiquitin ligase anaphase-promoting complex/ dergo glutaminolysis to meet their energy demands. As the first cyclosome (APC/C)-Cdh1, linking glutaminolysis to cell cycle enzyme in catalyzing glutaminolysis, human kidney-type glutamin- progression (12). In comparison, function and regulation of LGA is ase isoform (KGA) is becoming an attractive target for small not well studied, although it was recently shown to be linked to p53 pathway (13, 14). Although intense efforts are being made to de- molecules such as BPTES [bis-2-(5 phenylacetamido-1, 2, 4-thiadia- fi fi velop a speci c KGA inhibitor such as BPTES [bis-2-(5-phenyl- zol-2-yl) ethyl sul de], although the regulatory mechanism of KGA acetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide] (15), its mechanism remains unknown.
    [Show full text]
  • Transcription Factor Gata3 Expression Is Induced by Gls2 Overexpression in a Glioblastoma Cell Line but Is Gls2-Independent in Patient-Derived Glioblastoma
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2017, 68, 2, 209-214 www.jpp.krakow.pl E. MAJEWSKA1, R. ROLA2, M. BARCZEWSKA3, J. MARQUEZ4, J. ALBRECHT1, M. SZELIGA1 TRANSCRIPTION FACTOR GATA3 EXPRESSION IS INDUCED BY GLS2 OVEREXPRESSION IN A GLIOBLASTOMA CELL LINE BUT IS GLS2-INDEPENDENT IN PATIENT-DERIVED GLIOBLASTOMA 1Department of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland; 2Department of Neurosurgery and Paediatric Neurosurgery, Medical University of Lublin, Lublin, Poland; 3Department of Neurosurgery, Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Molecular Biology and Biochemistry, Faculty of Sciences, Campus de Teatinos, University of Malaga, Malaga, Spain Phosphate-activated glutaminase (GA), a ubiquitous glutamine-metabolizing enzyme, is encoded by two genes, GLS and GLS2. In mammalian cancers, GLS isoforms are perceived as molecules promoting cell proliferation and invasion, whereas the role of GLS2 isoforms seems to be more complex and cell type-specific. Previous studies have shown abundance of GLS and lack of GLS2 transcripts in T98G human glioblastoma (GBM) cell line and patient-derived GBM. Transfection with GAB sequence, the whole GLS2 cDNA transcript, suppressed malignant phenotype of T98G cells. Microarray analysis revealed upregulation of GATA3, the product of which has been implicated in suppressing growth of some peripheral cancers. In this study we confirmed a significant upregulation of GATA3 expression in the transfected cells both at mRNA and protein level. Considerable expression of GATA3 was also observed in GBM tissues (previously shown as not expressing GLS2), while only traces or no GATA3 was detected in (GLS2-expressing) non-tumorigenic brain samples.
    [Show full text]
  • GLS2 Mouse Monoclonal Antibody [Clone ID: OTI1C12] Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TA809492 GLS2 Mouse Monoclonal Antibody [Clone ID: OTI1C12] Product data: Product Type: Primary Antibodies Clone Name: OTI1C12 Applications: IHC, WB Recommended Dilution: WB 1:2000, IHC 1:2000 Reactivity: Human, Mouse, Rat Host: Mouse Isotype: IgG2a Clonality: Monoclonal Immunogen: Full length human recombiant protein of human GLS2 (NP_037399) produced in E.coli. Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. Concentration: 1 mg/ml Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) Conjugation: Unconjugated Storage: Store at -20°C as received. Stability: Stable for 12 months from date of receipt. Predicted Protein Size: 66.8 kDa Gene Name: glutaminase 2 Database Link: NP_037399 Entrez Gene 192268 RatEntrez Gene 216456 MouseEntrez Gene 27165 Human Q9UI32 Background: The protein encoded by this gene is a mitochondrial phosphate-activated glutaminase that catalyzes the hydrolysis of glutamine to stoichiometric amounts of glutamate and ammonia. Originally thought to be liver-specific, this protein has been found in other tissues as well. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013] Synonyms: GA; GLS; hLGA; LGA This product is to be used for laboratory only.
    [Show full text]
  • Phosphate-Activated Glutaminase (GLS2), a P53- Inducible Regulator
    Phosphate-activated glutaminase (GLS2), a p53- SEE COMMENTARY inducible regulator of glutamine metabolism and reactive oxygen species Sawako Suzukia,b,1, Tomoaki Tanakaa,b,1, Masha V. Poyurovskyc, Hidekazu Naganoa,b, Takafumi Mayamaa,b, Shuichi Ohkubod, Maria Lokshinc, Hiroyuki Hosokawae, Toshinori Nakayamae, Yutaka Suzukif, Sumio Suganof, Eiichi Satog, Toshitaka Nagaog, Koutaro Yokotea,b, Ichiro Tatsunoa,b,2, and Carol Privesc,2 aDepartment of Clinical Cell Biology and bDivision of Endocrinology and Metabolism, Chiba University Graduate School of Medicine, Chiba-shi, Chiba 260- 8670, Japan; cDepartment of Biological Sciences, Columbia University, New York, NY 10027; dDrug Discovery and Development I, Hanno Research Institute, Taiho Pharmaceutical Co., Ltd., Hanno, Saitama 357-8527, Japan; eDepartment of Immunology, Chiba University Graduate School of Medicine, Chiba-shi, Chiba 260-8670, Japan; fDepartment of Medical Genome Sciences, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Chiba 277-8562, Japan; and gDepartment of Anatomic Pathology, Tokyo Medical University, Shinjuku, Tokyo 160-0023, Japan Contributed by Carol Prives, March 1, 2010 (sent for review January 6, 2010) We identified a p53 target gene, phosphate-activated mitochondrial production as well as antioxidant defense through GSH synthesis. glutaminase (GLS2), a key enzyme in conversion of glutamine to glu- The two different phosphate activated GLS isoforms GLS1 (kid- tamate, and thereby a regulator of glutathione (GSH) synthesis and ney-type) and GLS2 (liver-type) in mammals are encoded by energy production. GLS2 expression is induced in response to DNA separate genes on different chromosomes (17–19). Previous data damage or oxidative stress in a p53-dependent manner, and p53 asso- have suggested that GLS1 up-regulation is associated with ciates with the GLS2 promoter.
    [Show full text]
  • Brain Glutaminases
    Article in press - uncorrected proof BioMol Concepts, Vol. 1 (2010), pp. 3–15 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BMC.2010.006 Review Brain glutaminases Javier Ma´rquez1,*, Mercedes Martı´n-Rufia´n1, glutarate involving tricarboxylic acid cycle (TCA) reactions Juan A. Segura1, Jose´ M. Mate´s1, Jose´A. has also been reported to contribute to generation of neuro- Campos-Sandoval2 and Francisco J. Alonso1 transmitter Glu (3). In addition to the transmitter pool of Glu in excitatory synapses, a metabolic pool also exists as this 1 Departamento de Biologı´a Molecular y Bioquı´mica, amino acid is a primary metabolic fuel for brain cells (4) Laboratorio de Quı´mica de Proteı´nas, Facultad de Ciencias, and a precursor of many other important metabolites (5). In Universidad de Ma´laga, 29071 Ma´laga, Spain fact, the mitochondrial breakdown of glutamine to pyruvate, 2 Marie Curie Membrane Proteins Laboratory, Biology known as glutaminolysis, is initiated by GA and has been Department, National University of Ireland, Maynooth, Co. Kildare, Ireland largely recognized as a fundamental process for energy sup- ply in the bioenergetics of many normal and transformed cell * Corresponding author types (6). e-mail: [email protected] The concentration of free Glu in mammalian brain is high- er than in any other organ (7). Glu is found in higher con- centrations than any other free amino acid in the central Abstract nervous system (8); however, it is a nonessential amino acid that crosses the blood-brain barrier relatively poorly (9) and Glutaminase is considered as the main glutamate producer hence it must be synthesized in the brain.
    [Show full text]
  • Glutaminase 2 Is a Novel Negative Regulator of Small Gtpase Rac1 and Mediates
    1 Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates 2 p53 function in suppressing metastasis 3 4 Cen Zhang,1,4 Juan Liu,1,4 Yuhan Zhao,1 Xuetian Yue,1 Yu Zhu,1 Xiaolong Wang,1 Hao Wu1, 5 Felix Blanco,1 Shaohua Li, 2 Gyan Bhanot,3 Bruce G Haffty, 1 Wenwei Hu,1,5 Zhaohui Feng,1,5 6 7 1 Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State 8 University of New Jersey, New Brunswick, NJ 08903, USA. 9 2 Department of Surgery, Robert Wood Johnson Medical School, Rutgers, The State University of 10 New Jersey, New Brunswick, NJ 08903, USA. 11 3 Department of Molecular Biology, Biochemistry & Physics, Rutgers, The State University of New 12 Jersey, Piscataway, NJ 08854, USA. 13 4 Co-first authors 14 5 Correspondence: W.H. (email: [email protected]) or Z.F. (email: [email protected]) 15 Running Title: GLS2 inhibits Rac1 to suppress metastasis 16 1 17 Abstract 18 Glutaminase (GLS) isoenzymes GLS1 and GLS2 are key enzymes for glutamine metabolism. 19 Interestingly, GLS1 and GLS2 display contrasting functions in tumorigenesis with elusive 20 mechanism; GLS1 promotes tumorigenesis, whereas GLS2 exhibits a tumor suppressive function. 21 In this study, we found that GLS2 but not GLS1 binds to small GTPase Rac1 and inhibits its 22 interaction with Rac1 activators guanine-nucleotide exchange factors (GEFs), which in turn inhibits 23 Rac1 to suppress cancer metastasis. This function of GLS2 is independent of GLS2 glutaminase 24 activity. Furthermore, decreased GLS2 expression is associated with enhanced metastasis in human 25 cancer.
    [Show full text]
  • Up-Regulation of Mir-330-5P Is Associated with the Advanced Clinical Stage of Hepatocellular Carcinoma
    Up-Regulation of MiR-330-5p is Associated with the Advanced Clinical Stage of Hepatocellular Carcinoma Hong-Yu Wei Guangxi Medical University He-Qing Huang Guangxi Medical University Gang Chen Guangxi Medical University Jie-Zhuang Huang Guangxi Medical University Yi-Wu Dang Guangxi Medical University Zhi-Guang Huang Guangxi Medical University Li-Min Liu Guangxi Medical University wei hou ( [email protected] ) Guangxi Medical University Research Keywords: Hepatocellular carcinoma, hsa-miR-330-5p, in house RT-qPCR, standard mean difference (SMD), summary receiver operating characteristic curve (sROC) Posted Date: April 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-384872/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/33 Abstract Purpose: A opposite expression levels and roles of miR-330-5p in hepatocellular carcinoma (HCC) have been reported in previous studies, so the clinicopathological implications and the prospective molecular mechanism of miR-330-5p in HCC require elaboration. Materials and methods: To examine the mRNA expression prole of hsa-miR-330-5p in HCC, a in-house RT-qPCR was performed, and the expression data was extracted from sequencing data and gene microarrays from the datasets of The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), ONCOMINE, ArrayExpress, and Sequence Read Archive (SRA). To have an overview of the clinical value of miR-330-5p, all possible data were integrated to calculate the standard mean difference (SMD) and area under the curve (AUC) from summary receiver operating characteristic curve (sROC). The target genes of miR-330-5p were also predicted and the relative signaling pathways were investigated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses.
    [Show full text]